Mission Not Accomplished

July 8, 2019 by C. Scott McMillin

It’s a real challenge for the folks on the ground to fit their reality into the prescribed format of a Federal grant.

Topics:


Esketamine Second Thoughts

July 4, 2019 by C. Scott McMillin

The first trials did not demonstrate effectiveness beyond placebo. So the FDA allowed a third trial which apparently did, at least a little.

Topics: ,


Life Without Opioids

June 24, 2019 by C. Scott McMillin

We shouldn’t ignore the emotional factors involved in chronic pain– such as anxiety and depression.

Topics: , ,


Stimulants Today

June 17, 2019 by C. Scott McMillin

The list of deaths from the practice is long and oddly prestigious, featuring celebs such as John Belushi and Chris Farley, among many others.

Topics: , ,


Microdosers

June 6, 2019 by C. Scott McMillin

If the dose is in fact subtherapeutic, then what causes the effects so enthusiastically reported by the user?

Topics:


Is Cannabis Addictive?

June 3, 2019 by C. Scott McMillin

The best answer is the one we came up with to explain the selectivity of alcoholism: Differences in individual susceptibility.

Topics: , ,


In the News: Magical Mushrooms

May 27, 2019 by C. Scott McMillin

Will society benefit from greater access to this drug? Are there potential problems we haven’t anticipated?

Topics:


Proposing a Plan

May 23, 2019 by C. Scott McMillin

This is in part a course correction from the trend of several decades ago, when the emphasis was on cutting expenses in the naive belief all addicts could be successfully treated on an outpatient basis.

Topics: ,


Coercion in Massachusetts

May 20, 2019 by C. Scott McMillin

I compare it to finding someone lying on the sidewalk, helping them up, brushing them off, and pushing them down again.

Topics: , , ,


Genetics of Heavy Drinking and Alcoholism

May 2, 2019 by C. Scott McMillin

Many so-called “heavy drinkers” do in fact meet criteria for an AUD, but quite a few do not.

Topics: , ,


Subscribe to RecoverySI via Email


New Content